This paper describes a randomized , blocked and multicentric clinical field study investigating the efficacy of an oral , chewable formulation containing milbemycin oxime/praziquantel ( Milbemax , Novartis Animal Health ) in the chemoprevention of subcutaneous dirofilariosis in dogs .